New proposed Medicare drug pricing models are unveiled
The College emphasizes that while fair pricing is essential, policies mustn't compromise drug availability or stifle research into new therapies.
We’re defending and empowering allergists
The ACAAI is the only allergy organization backed by Washington-based experts and consultants whose primary focus is allergy/immunology.
ACAAI applauds the latest expansion of GME slots
CMS announced the distribution of 400 new federally funded graduate medical education residency positions to hospitals across the country.
Medicare payment policies expire again
A brief lapse in funding is unlikely to trigger a full government shutdown of the agencies funded by the minibus
Claim denials for CPT code 95165 are growing
These requirements can significantly impact allergy practices that rely on preparing customized, multi-dose vials in advance.
The Senate HELP Committee seeks answers on CPT codes and coverage policies
Sen. Cassidy’s Request for Information (RFI) asks for specific data on the AMA’s licensing and royalty fees.
Issue with federal BCBS coverage of Xolair for IgE-mediated food allergy
Reports from members indicate that the FEP is denying coverage for Xolair unless the patient demonstrates confirmed allergies to peanuts plus at least two othe…
Food allergy testing guidance and coding
The cornerstone of effective food allergy diagnosis is a thorough clinical history.
Medicare denials for immunotherapy injections with venom immunotherapy
This issue began appearing last fall, affecting multiple Medicare Administrative Contractors (MACs). Denials typically cite reason code CO-50.
Congress passes ACAAI-backed Protecting Children with Food Allergies Act
This legislation represents an important step toward improving the safety and well-being of students with food allergies across the country.
2027 Medicare price reductions for asthma inhalers
CMS unveiled agreements with drug makers for sharply lower prices on 15 high-cost medications under Medicare's drug negotiation program.
College OIT Coding Recommendations
Always verify individual payer policies in writing before initiating OIT services, as coverage and accepted codes vary widely.
2026 MIPS Final Policies
CMS has finalized its proposal to maintain the 75-point performance threshold through the 2028 performance period.
Understanding the 2026 Medicare Physician Fee Schedule Final Rule
This article outlines important payment and policy changes that will shape reimbursement and practice operations for allergists in the coming year.
Adhering to USP 797 standards for in-office extract preparation
Compounding guidelines ensure patient safety by minimizing contamination, incorrect dosing, or other errors during sterile preparation.
Defend the allergy specialty
Our need to defend the allergy specialty is critical! These issues threaten our practices, specialty, and livelihoods.
Know the difference between build-up and dilution of allergy extracts
All seven MACs have now agreed in writing to cover the build-up phase of allergy extract preparation and administration.
CMS lifts temporary claims hold after series of confusing updates
Practices in areas with a work Geographic Practice Cost Indices (GPCI) factor less than 1.0 will have lower Medicare reimbursements.
Claims hold is impacting multiple services
CMS issued updated instructions clarifying that payments for select claims affected by expired legislative Medicare coverage policies should be held.
College seeks clarification on Cigna downcoding pause
We continue to encourage physicians and medical groups to voice their concerns until Cigna’s the policy is formally withdrawn.
